In the last trading session, 2.06 million Phio Pharmaceuticals Corp (NASDAQ:PHIO) shares changed hands as the company’s beta touched 0.84. With the company’s per share price at $2.96 changed hands at $0.5 or 20.33% during last session, the market valuation stood at $14.20M. PHIO’s last price was a discount, traded about -230.74% off its 52-week high of $9.79. The share price had its 52-week low at $0.97, which suggests the last value was 67.23% up since then.

Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information

Instantly PHIO was in green as seen at the end of in last trading. With action 48.00%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 64.44%, with the 5-day performance at 48.00% in the green. However, in the 30-day time frame, Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 45.10% up.

The estimates for the next quarter sales put growth at 0.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 66.30%. The 2025 estimates are for Phio Pharmaceuticals Corp earnings to increase by 82.60%, but the outlook for the next 5-year period is at 64.39% per year.

PHIO Dividends

Phio Pharmaceuticals Corp is expected to release its next quarterly earnings report in July.

Among Mutual Funds, the top two as of Mar 31, 2025 were Delaware Group Equity Funds IV-Macquarie Healthcare Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 50.0 shares estimated at $0.15 million under it, the former controlled 1.04% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.59% of the shares, roughly 28.43 shares worth around $84146.0.